| Roche - Bondronat (Ibandronate) For the treatment of metastatic bone disease in patients with breast cancer. Read More |
| Bondronat (ibandronic acid) - NetDoctor.co.uk - The UK's leading ... Bondronat tablets and injection contain the active ingredient ibandronic acid, which is a type of medicine called a bisphosphonate. Bisphosphonates are medicines that ... Read More |
| Bondronat consumer information from Drugs.com Bondronat (ibandronate) patient information. Detailed drug information for the consumer, includes dosage, Bondronat side effects and more. Read More |
| Bondronat | PrescriptionDrugs.com - PRESCRIPTION DRUGS Info and ... Bondronat is in the group of medicines called bisphosphonates (bis FOS fo nayts). It alters the cycle of bone formation and breakdown in the body. Read More |
| Ibandronic acid (Bondronat®) - Cancer Information - Macmillan ... Get information about ibandronic acid (Bondronat®), which can be used when breast cancer has spread to the bones Read More |
| Ibandronic acid - Wikipedia, the free encyclopedia Ibandronic acid (INN) or ibandronate sodium (USAN), marketed under the trade names Boniva, Bondronat and Bonviva, is a potent bisphosphonate drug used in the ... Read More |
| Buy Generic for Bondronat (Ibandronate) 6mg vials for Injection ... Anti-cancer medication Generic for Bondronat (Ibandronate) is available at low cost from our pharmacy. You can save up to $262.69 by ordering at International Drug Mart. Read More |
| European Medicines Agency - Find medicine - Bondronat This is a summary of the European Public Assessment Report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies ... Read More |
| Bondronat 50mg Film-coated Tablets (SPC) | Drugs.com Summary of Product Characteristics for Bondronat 50mg Film-coated Tablets. Detailed information for prescribers and healthcare professionals. Read More |
| Roche - European Approval for Bondronat in major additional indication Basel, 4 November 2003 European Approval for Bondronat in major additional indication Highly potent oral bisphosphonate set to fill unmet need for prevention of ... Read More |
